Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
168.35
-1.73 (-1.02%)
At close: Oct 9, 2026, 4:00 PM EDT
168.52
+0.17 (0.10%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Axsome Therapeutics Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Axsome Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $283.63. The average 1-year stock price forecast is 68.48% higher than the current stock price, while the lowest is $245 (+45.53%) and the highest is $380 (+125.72%).
Price Target: $283.63 (+68.48%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Axsome Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 17 | 17 | 18 | 18 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 21 | 21 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $276 | Buy | Maintains | $276 | +63.94% | Oct 9, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $297 → $295 | Buy | Maintains | $297 → $295 | +75.23% | Oct 8, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $280 | Buy | Maintains | $280 | +66.32% | Oct 6, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $256 | Buy | Reiterates | $256 | +52.06% | Oct 1, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Maintains $280 → $267 | Buy | Maintains | $280 → $267 | +58.60% | Sep 29, 2026 |
Financial Forecast
Revenue This Year
962.19M
from 638.50M
Increased by 50.70%
Revenue Next Year
1.55B
from 962.19M
Increased by 60.69%
EPS This Year
-2.72
from -3.47
EPS Next Year
4.70
from -2.72
EPS and Forward PE are based on non-GAAP adjusted numbers.